CD46 and neoplasm: Following Ad5/35-tk/GCV treatment, the average tumor volume was 48.55 ± 27.43 mm3 in the CD46-overexpressing group, 881.57 ± 141.72 mm3 in the CD46-reduced group, and 550.93 ± 74.39 mm3 in the vehicle group.